Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Vonoprazan
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
2 trials -
Vonoprazan
The First People's Hospital of Lianyungang
Ulcers, Gastric
1 trial -
Vonoprazan and Amoxicillin for the first 7 days
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Xingnaojing injection
The First People's Hospital of Lianyungang
Ischemic Stroke, Acute
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
a control group
The First People's Hospital of Lianyungang
Disorder of Stomach Function and Feeding Problems in Newborn
1 trial -
aspirin 100mg/d therapy
The First People's Hospital of Lianyungang
Coronary Atherosclerosis
1 trial -
aspirin and clopidogrel
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
berberine hydrochloride
The First People's Hospital of Lianyungang
Hypertension
1 trial -
butylphthalide(NBP)
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
dapagliflozin
The First People's Hospital of Lianyungang
Diabetic Kidney Disease
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Aged
3 trials -
dexmedetomidine hydrochloride for injection
The First People's Hospital of Lianyungang
Delirium
1 trial -
entecavir
The First People's Hospital of Lianyungang
Liver Fibrosis
1 trial -
ginkgolide
The First People's Hospital of Lianyungang
Intravenous Alteplase Thrombolysis
1 trial -
half-dose ticagrelor
The First People's Hospital of Lianyungang
Acute Coronary Syndrome
1 trial -
hydrochloride hydromorphone + flurbiprofen axetil
The First People's Hospital of Lianyungang
Enhanced Recovery After Surgery
1 trial -
insulin lispro injection, exenatide injection
The First People's Hospital of Lianyungang
Diabetes Mellitus, Type 2
1 trial -
intravenous tranexamic acid (TXA) infusion
The First People's Hospital of Lianyungang
Spontaneous Intracranial Hemorrhage
1 trial -
iodixanol
The First People's Hospital of Lianyungang
Kidney Failure, Chronic
1 trial -
lorlatinib
The First People's Hospital of Lianyungang
NSCLC
1 trial -
low-dose ticagrelor
The First People's Hospital of Lianyungang
Coronary Artery Disease
1 trial -
low-dose ticagrelor
The First People's Hospital of Lianyungang
Platelet Reactivity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources